3 Stocks Estimated To Be Trading Below Fair Value By Up To 49.9%

Over the last 7 days, the United States market has risen by 2.9%, and over the past 12 months, it is up by 14%, with earnings forecasted to grow by 15% annually. In this thriving environment, identifying stocks that are trading below their fair value can present opportunities for investors seeking to capitalize on potential growth while maintaining a focus on intrinsic value.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Click here to see the full list of 173 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Symbotic (SYM)

Overview: Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses, with a market cap of $21.96 billion.

Operations: The company generates revenue of $2.07 billion from its Industrial Automation & Controls segment.

Estimated Discount To Fair Value: 49.9%

Symbotic's stock is trading at US$38.85, significantly below its estimated fair value of US$77.61, suggesting undervaluation based on discounted cash flow analysis. Despite high share price volatility recently, the company has shown consistent earnings growth of 9.4% annually over the past five years and is expected to achieve profitability within three years, with forecasted revenue growth outpacing the broader US market. Recent executive changes include a new CFO appointment to support financial strategy execution.

• Our growth report here indicates Symbotic may be poised for an improving outlook.
• Delve into the full analysis health report here for a deeper understanding of Symbotic.

Privia Health Group (PRVA)

Overview: Privia Health Group, Inc. is a national physician-enablement company in the United States with a market cap of approximately $2.68 billion.

Operations: The company generates revenue primarily through its Healthcare Facilities & Services segment, which accounts for $1.80 billion.

Estimated Discount To Fair Value: 44.1%

Privia Health Group's stock, at US$23, is trading significantly below its estimated fair value of US$41.16, highlighting potential undervaluation based on cash flows. The company reported a strong Q1 with sales of US$480.1 million and net income growth to US$4.22 million. Earnings are projected to grow 32.45% annually over the next three years, outpacing the broader market despite recent insider selling activity and low forecasted return on equity at 11.5%.

• Upon reviewing our latest growth report, Privia Health Group's projected financial performance appears quite optimistic.
• Navigate through the intricacies of Privia Health Group with our comprehensive financial health report here.

Hinge Health (HNGE)

Overview: Hinge Health, Inc. develops healthcare software focused on joint and muscle health, with a market cap of $3.63 billion.

Operations: The company's revenue is derived entirely from its healthcare software segment, amounting to $431.52 million.

Estimated Discount To Fair Value: 47.5%

Hinge Health's stock, trading at US$51.75, is significantly undervalued compared to its estimated fair value of US$98.55, according to discounted cash flow analysis. The company has recently launched HingeSelect, enhancing its musculoskeletal care offerings and reducing costs for employers by up to 50% below PPO rates. Despite being forecasted as unprofitable in three years, earnings are expected to grow significantly at 22.95% annually over the next three years, outpacing market averages.

• Our earnings growth report unveils the potential for significant increases in Hinge Health's future results.
• Unlock comprehensive insights into our analysis of Hinge Health stock in this financial health report.

Where To Now?

• Embark on your investment journey to our 173 Undervalued US Stocks Based On Cash Flows selection here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com